FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34812511000001102: Reslizumab 25mg/2.5ml solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105303401000001111 Reslizumab 25mg/2.5ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105303501000001110 Reslizumab 25mg/2.5ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reslizumab 25mg/2.5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Is a Reslizumab true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Is a Reslizumab false Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has specific active ingredient Reslizumab true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Is a True Reslizumab 25mg/2.5ml solution for infusion vials Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Has VMP True Reslizumab 25mg/2.5ml solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start